| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of WDR61 mRNA | CTD | PMID:22079256 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:1551430 | 6480464 | Ethinyl Estradiol affects the expression of WDR61 mRNA | CTD | PMID:17555576 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551430 | 6480464 | Tetrachlorodibenzodioxin affects the expression of WDR61 mRNA | CTD | PMID:21570461 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1308228 | 6480464 | 2,4-dinitrotoluene affects the expression of WDR61 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:1308228 | 6480464 | 2,6-dinitrotoluene affects the expression of WDR61 mRNA | CTD | PMID:21346803 |
| 3-methylcholanthrene | increases expression | ISO | RGD:1551430 | 6480464 | Methylcholanthrene results in increased expression of WDR61 mRNA | CTD | PMID:20713471 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of WDR61 mRNA] | CTD | PMID:15016801 |
| aflatoxin B1 | increases expression | ISO | RGD:1551430 | 6480464 | Aflatoxin B1 results in increased expression of WDR61 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1551430 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of WDR61 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:1551430 | 6480464 | Benzo(a)pyrene results in increased expression of WDR61 mRNA | CTD | PMID:19770486 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1308228 | 6480464 | Benzo(a)pyrene results in increased expression of WDR61 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | increases expression | ISO | RGD:1551430 | 6480464 | Benzo(a)pyrene results in increased expression of WDR61 mRNA | CTD | PMID:19770486 |
| clofibric acid | multiple interactions | ISO | RGD:1308228 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of WDR61 mRNA | CTD | PMID:17602206 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of WDR61 mRNA | CTD | PMID:19549813 |
| doxorubicin | affects response to substance | EXP | | 6480464 | WDR61 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 |
| isotretinoin | decreases expression | EXP | | 6480464 | Isotretinoin results in decreased expression of WDR61 mRNA | CTD | PMID:20436886 |
| lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of WDR61 mRNA | CTD | PMID:19921347 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1308228 | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of WDR61 mRNA | CTD | PMID:17602206 |
| paclitaxel | affects response to substance | EXP | | 6480464 | WDR61 protein affects the susceptibility to Paclitaxel | CTD | PMID:16217747 |
| paracetamol | affects expression | ISO | RGD:1551430 | 6480464 | Acetaminophen affects the expression of WDR61 mRNA | CTD | PMID:17562736 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of WDR61 mRNA | CTD | PMID:21632981 |
| tamoxifen | affects expression | ISO | RGD:1551430 | 6480464 | Tamoxifen affects the expression of WDR61 mRNA | CTD | PMID:17555576 |
| vincaleukoblastine | affects response to substance | EXP | | 6480464 | WDR61 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 |